“…In vitro antitumor activity IC 50 (ng mL -1 ) of compounds 42-44 against the cell lines MCF 7 and EVSA T (two types of breast cancers), IGROV (ovarian cancer), M19 MEL (skin cancer, melanoma), and A498 (renal cancer) compared to the clinically used drugs, carborane o C 2 B 10 H 12 , and (m C 2 B 10 H 11 9) 2 SnCl 2(39) …”